Estrella Immunopharma Inc. (ESLA) — Financial Flexibility Index
Estrella Immunopharma Inc. (ESLA) has a Financial Flexibility Index of -0.75x as of March 2026. Free cash flow of $-6.70 Million (operating CF $-6.70 Million minus capex $0.00) represents -1% of total liabilities ($8.93 Million). Check Estrella Immunopharma Inc. strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Estrella Immunopharma Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Estrella Immunopharma Inc. across 5 annual periods. See working capital position of Estrella Immunopharma Inc. to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Estrella Immunopharma Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Estrella Immunopharma Inc.. For the full company profile including market capitalisation, see Estrella Immunopharma Inc. market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.13x | $-1.79 Million | $-1.79 Million | $13.54 Million | ▲ +94.8% |
| 2024 | -2.55x | $-7.64 Million | $-7.64 Million | $3.00 Million | ▲ +97.1% |
| 2023 | -88.92x | $-16.07 Million | $-16.07 Million | $180.70K | ▼ -24738.1% |
| 2022 | -0.36x | $-1.04 Million | $-1.04 Million | $2.92 Million | ▼ -48.0% |
| 2021 | -0.24x | $-1.44 Million | $-1.44 Million | $5.96 Million | — |